Skip to main content
SpringerLink
Log in

Phase II study of lonidamine in metastatic prostatic carcinoma

  • Clinical Studies
  • Brief Report
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Catalona WJ: Prostate Cancer. Grune and Stratton, Inc., Orlando, FL, 1984

    Google Scholar 

  2. Tannock IF: Is there evidence that chemotherapy is of benefit to patients with carcinoma of prostate? J Clin Oncol 3:1013–1021, 1985

    Google Scholar 

  3. Evans WK, Shepherd FA, Mullis B: Phase II evaluation of lonidamine in patients with advanced malignancy. Oncology 41 (Suppl 1):69–77, 1984

    Google Scholar 

  4. Eisenberger MA, Simon R, O'Dwyer PJ, Wittes RE, Friedman, MA: A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma. J Clin Oncol 3:827–841, 1985

    Google Scholar 

  5. Kim JH, Alfieri A, Kim SH, Young CW, Silvestrini B: Radiosensitization of Meth-A fibrosarcoma in mice by lonidamine. Oncol 41 (Suppl 1):36–38, 1984

    Google Scholar 

  6. Zupi G, Greco C, Laudonio N, Benassi M, Silvestrini B, Caputo A: In vitro and in vivo potentiation by lonidamine of the antitumor effect of Adriamycin. Anticancer Res 6:1245–1250, 1986

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Ontario Cancer Treatment and Research Foundation Ottawa Regional Cancer Center and the University of Ottawa Faculty of Medicine, Ottawa, Canada

    David J. Stewart (Professor of Medicine and Pharmacology, Head, Division of Medical Oncology), Susan E. Aitken, Allen H. Irvine, David E. Moors & Norman G. Futter

Authors
  1. David J. Stewart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan E. Aitken
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Allen H. Irvine
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David E. Moors
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Norman G. Futter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stewart, D.J., Aitken, S.E., Irvine, A.H. et al. Phase II study of lonidamine in metastatic prostatic carcinoma. Invest New Drugs 9, 343–344 (1991). https://doi.org/10.1007/BF00183577

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00183577

key words

Search

Navigation